Icahn Gets 2 Seats On Genzyme Board In Proxy Deal
Genzyme Corp. and billionaire investor Carl C. Icahn on Wednesday reached a settlement in their proxy dispute, a week before the troubled biotechnology company's annual shareholder meeting....To view the full article, register now.
Already a subscriber? Click here to view full article